GeneDx Holdings Corp(WGS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 28 at 6:35 PM ET (Korea 10/29 07:35)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -3.63 | Insider Own | 3.1% | Shs Outstand | 29.8M | Perf Week | -6.16% |
| Market Cap | 1.93B | Forward P/E | 53.96 | EPS next Y | 1098.8% | Insider Trans | 239.56% | Shs Float | 28.9M | Perf Month | -14.65% |
| Enterprise Value | 1.96B | PEG | 6.48 | EPS next Q | 0.07 | Inst Own | 105.02% | Short Float | 20.83% | Perf Quarter | -6.19% |
| Income | -0.11B | P/S | 4.25 | EPS this Y | -92.86% | Inst Trans | -8.07% | Short Ratio | 7.82 | Perf Half Y | 2.85% |
| Sales | 0.45B | P/B | 7.89 | EPS next 5Y | 8.33% | ROA | -22.5% | Short Interest | 6.02M | Perf YTD | -50.26% |
| Book/sh | 8.19 | P/C | 14.55 | EPS past 3/5Y | 76.08% 94.57% | ROE | -40.8% | 52W High | -62.14% ($170.87) | Perf Year | -52.94% |
| Cash/sh | 4.44 | P/FCF | - | Sales past 3/5Y | 22.13% 18.98% | ROIC | -26.2% | 52W Low | 100.84% ($32.21) | Perf 3Y | 2115.41% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -10900% | Gross Margin | 64.81% | Volatility(W/M) | 10.66% 8.56% | Perf 5Y | -76.27% |
| Dividend TTM | - | EV/Sales | 4.32 | Sales Y/Y TTM | 25.42% | Oper. Margin | -12.49% | ATR (14) | 5.75 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.06 | EPS Q/Q | -264.35% | Profit Margin | -23.4% | RSI (14) | 43.19 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.3 | Sales Q/Q | 11.44% | SMA20 | -3.63% ($67.13) | Beta | 2.01 | Target Price | $93.5 |
| Payout | - | Debt/Eq | 0.69 | Earnings | 2026/11/9 | SMA50 | -18.61% ($79.48) | Rel Volume | 0.74 | Prev Close | $62.74 |
| Employees | 1300 | LT Debt/Eq | 0.66 | EPS/Sales Surpr. | 105.32% 3.09% | SMA200 | -10.52% ($72.3) | Avg Volume(3M) | 0.77M | Price | $64.69 |
| IPO | 2020/11/4 | Option/Short | Yes/Yes | Trades | 8499 | Volume | 573,117 | Change | 3.11% |
🧬 This is a US diagnostics company that provides genome-based genetic testing. It offers genetic tests that leverage exome and whole-genome analysis to diagnose rare and genetic diseases, identifying the causes of genetic disorders in children and newborns. The company has established itself as a diagnostics provider specializing in rare genetic disease diagnosis, combining genomic testing with data-driven interpretation.
Over the past 1 year, on the lower side
62% below its 1-year high.
Traded less than usual. That is 74% of its average volume.
Next earnings report: November 9
12 days to go.
WGS has a sound balance sheet but weak earning power
Of every $100 in sales, $12.49 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -92.9% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $425. Peers typically go for $458.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -76.3%. The S&P 500 did +69% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Short interest is a burden
20.8% of the float is sold short.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #26 of 44 in the industry
Based on market cap of $2B.
NEO#25 Neogenomics Inc $2B PER - WGS#26 GeneDx Holdings Corp $2B PER - 
PSNL#27 Personalis Inc $2B PER - 
FRNM#28 Freenome Inc $1B PER - 
OPK#29 Opko Health Inc $1B PER - 
FAQ
What kind of company is WGS?
WGS belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of WGS?
The market cap of WGS is approximately $1.9B, ranking 2,087 within its sector.
What is the 52-week high and low for WGS?
WGS has recorded a 52-week high of $170.87 and a low of $32.21.
